ACC: Niacin/Laropiprant no benefit in vascular disease
(HealthDay)—For patients with preexisting occlusive vascular disease, the combination of niacin and the anti-flushing agent laropiprant provides no benefit and is associated with an increase in serious ...
Cardiology
Mar 12, 2013 |
not rated yet |
0
Ocular complications common after pediatric HSCT
(HealthDay)—For pediatric patients undergoing hematopoietic stem cell transplantation (HSCT), complications are common, but are generally mild and self-limiting, according to a study published online Feb. ...
Ophthalmology
Mar 01, 2013 |
not rated yet |
0
USPSTF: Vitamin D, calcium supplements don't prevent fx
(HealthDay)—For non-institutionalized postmenopausal women, the U.S. Preventive Services Task Force (USPSTF) recommends against daily supplementation with ≤400 IU of vitamin D3 and ≤1,000 mg of calcium for primary prevention of fractures, and a lack of e ...
Health
Feb 26, 2013 |
not rated yet |
0
Virus shows promise as prostate cancer treatment
A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of print in the Journal of ...
Cancer
Feb 25, 2013 |
5 / 5 (3) |
0
|
Corticorelin acetate has steroid-sparing effect in brain cancer
(HealthDay)—Corticorelin acetate (CrA) administration to patients with peritumoral brain edema (PBE) allows the reduction of steroid doses and is associated with reduced incidence and severity of steroid-induced ...
Cancer
Feb 06, 2013 |
4 / 5 (1) |
0
Personalized medicine eliminates need for drug in two children
Using genome-wide analysis, investigators at the Sainte-Justine University Hospital Research Center and the University of Montreal have potentially eliminated a lifetime drug prescription that two children with a previously ...
Genetics
Jan 31, 2013 |
not rated yet |
0
|
Chronic hepatitis C: Interferon may be harmful in re-treatment
People with hepatitis C and chronic liver disease who relapsed or failed to respond to initial treatment are unlikely to improve on interferon retreatment. In fact, they may face an increased risk of dying sooner, and are ...
Diseases, Conditions, Syndromes
Jan 30, 2013 |
not rated yet |
0
Cancer expert remains to be convinced by breast screening review
Michael Baum, Professor emeritus of surgery at University College London says that, while deaths from breast cancer may be avoided, any benefit will be more than outweighed by deaths due to the long term adverse effects of ...
Cancer
Jan 24, 2013 |
not rated yet |
0
Rheumatism drug also effective at half dose
The treatment of moderately active rheumatoid arthritis with the tumour necrosis factor inhibitor Etanercept achieves excellent success in more than 80 per cent of patients. With this method, the success ...
Arthritis & Rheumatism
Jan 18, 2013 |
not rated yet |
0
Alternative med use common in pediatric specialty outpatients
(HealthDay)—Complementary and alternative medicine (CAM) is commonly used among pediatric specialty outpatients, according to a study published online Jan. 14 in Pediatrics.
Pediatrics
Jan 14, 2013 |
not rated yet |
0
Spin and bias in published studies of breast cancer trials
Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to new research published in the cancer journal Annals of ...
Cancer
Jan 09, 2013 |
not rated yet |
0
|
Reduction in air pollution from wood stoves associated with significantly reduced risk of death
Male deaths from all-causes, but particularly cardiovascular and respiratory disease, could be significantly reduced with a decrease in biomass smoke (smoke produced by domestic cooking and heating and woodland fires), a ...
Health
Jan 08, 2013 |
not rated yet |
1
Indication of considerable added benefit of vemurafenib in advanced melanoma
Vemurafenib has been approved since February 2012 for the treatment of certain groups of adults with advanced melanoma. The drug offers major advantages in terms of survival, but also causes major side effects. Overall, there ...
Cancer
Jan 08, 2013 |
not rated yet |
0
Patients with diabetes may not receive best treatment to lower heart disease risk
For some people with diabetes, there may be such a thing as too much care.
Diabetes
Dec 18, 2012 |
not rated yet |
0
'Synthetic pot' sending thousands of young people to ER
(HealthDay)—U.S emergency rooms tended to more than 11,400 cases of drug-related health complications specifically linked to the use of synthetic marijuana in 2010, a new government report reveals.
Addiction
Dec 04, 2012 |
not rated yet |
1
